FDA Approval for LDTs Made Easy

The FDA's recent decision to cease its enforcement discretion for lab-developed tests (LDTs) has significant implications for developers. To ensure compliance, developers must adhere to a rigorous process. Key steps include:1) Develop a risk-based framework- 0:39- 1:032) Get pre-market clearance or approval- 1:04- 1:373) Quality control and quality assurance- 1:38- 2:044) Adhering to FDA guidelines for labeling and marketing- 2:05- 2:215) Ensuring data security and patient privacy- 2:22-...

Om Podcasten

Welcome to DarshanTalks! We demystify fraud for legal, regulatory, and compliance essentials in the life sciences and pharmacy industries. Through engaging 15-30-minute interviews with influential change makers, short educational regulatory defbriefs, and 60 second audio takeaways, we unveil the strategies behind bringing drugs and devices to market—and keeping them there! Powered By The Kulkarni Law Firm -  Helping regulators see your business the way you do. We focus on life science issues involving medical affairs, marketing and advertising, and clinical research so that you can learn about the industry, enhance your business and grow your career.